Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciliberto

Showing results (391-400 of 838) with videos related to

Pageof 84
Sort By:
The European Journal of Neuroscience|April 24, 1999
Presence of a reduced opioid response in interleukin-6 knock out miceM Bianchi, R Maggi, F Pimpinelli, et al.
The Journal of Clinical Investigation|February 15, 1997
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammationF De Benedetti, T Alonzi, A Moretta, et al.
Attention Deficit and Hyperactivity Disorders|November 30, 2013
The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysisFranco De Crescenzo, Marco Armando, Luigi Mazzone, et al.
Journal of Clinical Medicine|June 28, 2023
Analysis of Short-Term Clinical and Functional Outcomes in Patients Undergoing Total Knee Arthroplasty with Kinematic Alignment TechniqueRiccardo Giorgino, Alessandra Nannini, Edoardo Scuttari, et al.
Cancer Treatment Reviews|July 1, 2016
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?Piera Gargiulo, Chiara Della Pepa, Simona Berardi, et al.
Current Biology : CB|December 19, 2017
Cells Escape an Operational Mitotic Checkpoint through a Stochastic ProcessPaolo Bonaiuti, Elena Chiroli, Fridolin Gross, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
European Journal of Biochemistry|January 15, 1993
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coliR Arcone, G Arpaia, M Ruoppolo, et al.
Journal of Child Neurology|September 23, 2016
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic PhasesJacqueline S Gofshteyn, Angus Wilfong, Orrin Devinsky, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 84

Showing results (391-400 of 838) with videos related to

Sort By:
Pageof 84
The European Journal of Neuroscience|April 24, 1999
Presence of a reduced opioid response in interleukin-6 knock out miceM Bianchi, R Maggi, F Pimpinelli, et al.
The Journal of Clinical Investigation|February 15, 1997
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammationF De Benedetti, T Alonzi, A Moretta, et al.
Attention Deficit and Hyperactivity Disorders|November 30, 2013
The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysisFranco De Crescenzo, Marco Armando, Luigi Mazzone, et al.
Journal of Clinical Medicine|June 28, 2023
Analysis of Short-Term Clinical and Functional Outcomes in Patients Undergoing Total Knee Arthroplasty with Kinematic Alignment TechniqueRiccardo Giorgino, Alessandra Nannini, Edoardo Scuttari, et al.
Cancer Treatment Reviews|July 1, 2016
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?Piera Gargiulo, Chiara Della Pepa, Simona Berardi, et al.
Current Biology : CB|December 19, 2017
Cells Escape an Operational Mitotic Checkpoint through a Stochastic ProcessPaolo Bonaiuti, Elena Chiroli, Fridolin Gross, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
European Journal of Biochemistry|January 15, 1993
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coliR Arcone, G Arpaia, M Ruoppolo, et al.
Journal of Child Neurology|September 23, 2016
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic PhasesJacqueline S Gofshteyn, Angus Wilfong, Orrin Devinsky, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 84